Tania Tamara Herrera

Dr. Tania Tamara Herrera

Obstetric and Gynecology, Hospital Pacifica Salud, Panama City, Panama
+1
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2023 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
AAAndrea Kaelin Agten
Andrea Kaelin Agten
DJDavor Jurkovic
Davor Jurkovic
ITIlan Timor-Tritsch
Ilan Timor-Tritsch
NJNia Jones
Nia Jones
SJSusanne Johnson
Susanne Johnson
EWEwa Wender-Ozegowska
Ewa Wender-Ozegowska
Cesarean scar pregnancy (CSP) is an iatrogenic consequence of a prior cesarean delivery (CD). The gestational sac implants into a niche created by the incision of the previous CD, carrying a substantial risk for major maternal complications. The aim of this study is to report, analyze and compare effectiveness and safety of different treatments options of CSP managed in the first trimester through a registry. To study the ultrasound findings, disease behavior, and management of first trimester CSP. We created an international registry of CSP to study the ultrasound findings, disease behavior, and management of CSP. The CSP-registry collects anonymized ultrasound and clinical data of individual CSP patients on a secure digital information platform. Cases were uploaded by 31 participating centers in 19 countries. In this study we only included live and failing CSP (with or without positive fetal heart beat) who received active treatment (medical or surgical) before 12+6 weeks' gestation in order to evaluate effectiveness and safety of the different management options. Patients managed expectantly were not included in this study and will be reported separately. Treatment was classified as successful if it led to a complete resolution of pregnancy without the need for any additional medical intervention. Between 29 August 2018 and 28 February 2023, we recorded 460 patients with CSP (281 live, 179 failing CSP) who fulfilled the inclusion/exclusion and were registered. 270/460 (58.7%) patients were managed surgically, 123/460 (26.7%) underwent medical management, 46/460 (10%) underwent balloon management and 21/460 (4.6%) underwent other, less frequently used treatment options. Suction evacuation was very effective, with 202/221(91.5%, 95%CI 87.8-95.2) success rate whilst systemic methotrexate was least effective with only 38/64 (59.4%, 95% CI 48.4-70.4) patients not requiring additional treatment. Overall, surgical treatment of CSP was successful in 236/258 (91.5%, 95% CI 88.4-94.5) and the complication rate was 24/258 (9.3%, 95% CI 6.6-11.9). CSP in the first trimester of pregnancy can be managed effectively in more than 90% of cases with either suction evacuation, balloon treatment or surgical excision. The effectiveness of all treatment options decreases with advancing gestational age CSP should be treated as early as possible after confirmation of the diagnosis. Local medical treatment with KCl or methotrexate is less efficient in and has higher rates of complications compared to the other treatment options. Systemic methotrexate has a substantial risk of failing and a higher complication rate and should not be recommended as first line treatment.

8 August 2020 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
Tania Tamara HerreraTania Tamara Herrera
Tania Tamara Herrera
KRKatia Rueda
Katia Rueda
HEHonorina Espinosa
Honorina Espinosa
GBGabrielle Britton
Gabrielle Britton
Background: Twin reversed arterial perfusion sequence is a rare and potentially lethal condition affecting approximately 1% of monochorionic twin pregnancies and 1 in 35,000 pregnancies overall. An apparently normal (pump) twin perfuses its severely malformed cotwin with deoxygenated blood via retrograde flow in direct arterioarterial anastomoses between the umbilical arteries of each twin. Fetal intestinal volvulus is a rare condition usually manifesting after birth. We report a unique case of twin reversed arterial perfusion sequence in association with intestinal volvulus in the surviving pump twin.Case presentation: A 32-year-old Hispanic primigravida was referred to our clinic after a fetoscopy procedure of laser photocoagulation of anastomoses at 18 weeks of gestation. Follow up scans in the ex-pump twin revealed dilated bowel loops and a typical “whirlpool sign” at 26 weeks of gestation, and intrauterine intestinal volvulus was suspected. At 29 weeks of gestation, preterm premature rupture of membranes occurred, and an emergency cesarean section was performed. The newborn was diagnosed in the early neonatal period with intestinal perforation. The diagnosis was postnatally confirmed by surgery and histopathology.Conclusions: The type of fetal intervention and late gestational age of the procedure increase the risk of complications. This case alerts health providers to be vigilant in the follow-up of patients with complicated monochorionic pregnancies.

29 September 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
Tania Tamara HerreraTania Tamara Herrera
Tania Tamara Herrera
ICIdalina Cubilla-Batista
Idalina Cubilla-Batista
AGAmador Goodridge
Amador Goodridge
TPTiago V. Pereira
Tiago V. Pereira
Objective: The aim of this study was to assess the accuracy of prenatal imaging for the diagnosis of congenital Zika syndrome.Data sources: Medline (via Pubmed), PubMed, Scopus, Web of Science, and Google Scholar from inception to March 2022. Two researchers independently screened study titles and abstracts for eligibility.Study eligibility criteria: Observational studies with Zika virus-infected pregnant women were included. The index tests included ultrasound and/or magnetic resonance imaging. The reference standard included (1) Zika infection-related perinatal death, stillbirth, and neonatal death within the first 48 h of birth, (2) neonatal intensive care unit admission, and (3) clinically defined adverse perinatal outcomes.Synthesis methods: We extracted 2 × 2 contingency tables. Pooled sensitivity and specificity were estimated using the random-effects bivariate model and assessed the summary receiver operating characteristic (ROC) curve. Risk of bias was assessed using QUADAS 2 tool. The certainty of the evidence was evaluated with grading of recommendations.Results: We screened 1,459 references and included 18 studies (2359 pregnant women, 347 fetuses with confirmed Zika virus infection). Twelve studies (67%) were prospective cohorts/case series, and six (37%) were retrospective cohort/case series investigations. Fourteen studies (78%) were performed in endemic regions. Ten studies (56%) used prenatal ultrasound only, six (33%) employed ultrasound and fetal MRI, and two studies (11%) used prenatal ultrasound and postnatal fetal MRI. A total of six studies (ultrasound only) encompassing 780 pregnant women (122 fetuses with confirmed Zika virus infection) reported relevant data for meta-analysis (gestation age at which ultrasound imagining was captured ranged from 16 to 34 weeks). There was large heterogeneity across studies regarding sensitivity (range: 12 to 100%) and specificity (range: 50 to 100%). Under a random-effects model, the summary sensitivity of ultrasound was 82% (95% CI, 19 to 99%), and the summary specificity was 97% (71 to 100%). The area under the ROC curve was 97% (95% CI, 72 to 100%), and the summary diagnostic odds ratio was 140 (95% CI, 3 to 7564, P < 0.001). The overall certainty of the evidence was “very low”.Conclusion: Ultrasound may be useful in improving the diagnostic accuracy of Zika virus infection in pregnancy. However, the evidence is still substantially uncertain due to the methodological limitations of the available studies. Larger, properly conducted diagnostic accuracy studies of prenatal imaging for the diagnosis of congenital Zika syndrome are warranted.Systematic review registration: Identifier [CRD42020162914].

4 January 2017 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
Tania Tamara HerreraTania Tamara Herrera
Tania Tamara Herrera
JGJillian L. Garcia
Jillian L. Garcia
GBGabrielle Britton
Gabrielle Britton
Objective: Increasing maternal weight has been shown to predict adverse perinatal outcome, including increases in the relative risk of fetal death, stillbirth, neonatal death, perinatal death and infant death. In order to better understand the pathophysiological factors associated with obesity during pregnancy, the role of biomarkers associated with adverse outcomes in obese pregnant women is under investigation. The purpose of this review study was to examine potential biomarkers that could serve as effective screening strategies in obese pregnant women to reduce fetal and neonatal morbidity, as well as maternal morbidity. Methods: Electronic databases (Pubmed, Embase) were searched for previously published research studies that investigated biomarkers associated with perinatal outcomes in obese pregnant women and the putative mechanisms underlying biomarker effects on pregnancy outcomes. Results: It is evident that while several biomarkers predict perinatal complications in obese pregnant women, none fulfilled the criteria to be considered clinically useful. Conclusion: There is a critical need for reliable blood-based biomarkers associated with an increased risk of adverse perinatal outcomes in obese pregnant women.

1 July 2021 in Clínica E Investigación En Ginecología Y Obstetricia
Verified
Journal Article
Closed access
Tania Tamara HerreraTania Tamara Herrera
Tania Tamara Herrera
ICI. Cubilla-Batista
I. Cubilla-Batista
CBC.B. Britton
C.B. Britton
AGA. Goodridge
A. Goodridge